Bipin N Savani

Bipin N Savani

UNVERIFIED PROFILE

Are you Bipin N Savani?   Register this Author

Register author
Bipin N Savani

Bipin N Savani

Publications by authors named "Bipin N Savani"

Are you Bipin N Savani?   Register this Author

100Publications

3031Reads

19Profile Views

Role of Physical Therapy before and after Hematopoietic Stem Cell Transplantation: White Paper Report.

Biol Blood Marrow Transplant 2019 Jun 15;25(6):e191-e198. Epub 2019 Jan 15.

Physical Therapy Association for Graft Versus Host Disease, Swindon, United Kingdom; Oncology Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; Department of Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791193006
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2019.01.018DOI Listing
June 2019

ASBMT Statement on Routine Prophylaxis for Central Nervous System Recurrence of Acute Lymphoblastic Leukemia following Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2019 Mar 25;25(3):e86-e88. Epub 2018 Dec 25.

Adult BMT Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183162
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.12.757DOI Listing
March 2019

Transgender individuals represent an overlooked population amongst stem cell donors.

Bone Marrow Transplant 2019 Jan 18. Epub 2019 Jan 18.

Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0437-0DOI Listing
January 2019

Reduced Relapse Incidence with FLAMSA-RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Biol Blood Marrow Transplant 2018 11 7;24(11):2224-2232. Epub 2018 Aug 7.

Hematology Division and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer and Tel Aviv University, Tel-Aviv, Israel; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.07.007DOI Listing
November 2018

Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program.

Biol Blood Marrow Transplant 2018 10 9;24(10):2081-2087. Epub 2018 May 9.

Division of Infectious Diseases, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.04.031DOI Listing
October 2018

Varicella Zoster Virus Reactivation in Adult Survivors of Hematopoietic Cell Transplantation: How Do We Best Protect Our Patients?

Biol Blood Marrow Transplant 2018 09 10;24(9):1783-1787. Epub 2018 Apr 10.

Department of Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden; Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.04.003DOI Listing
September 2018

Leukaemia risk associated with low-dose radiation.

Lancet Haematol 2018 08 17;5(8):e324-e325. Epub 2018 Jul 17.

Hematology and Stem Cell Transplantation Section, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(18)30106-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097528PMC
August 2018

Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia.

Bone Marrow Transplant 2018 06 14;53(6):795-799. Epub 2018 Mar 14.

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0124-6DOI Listing
June 2018

Optimizing Antithymocyte Globulin Dosing for Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Based on Recipient Absolute Lymphocyte Count.

Biol Blood Marrow Transplant 2018 01 30;24(1):150-155. Epub 2017 Aug 30.

Division of Hematology/Oncology, Stem Cell Transplantation, Department of Medicine, Vanderbilt University, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.08.029DOI Listing
January 2018

Measuring Immune Response to Commonly Used Vaccinations in Adult Recipients of Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2017 Oct 15;23(10):1614-1621. Epub 2017 Jun 15.

Department of Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden; Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.06.006DOI Listing
October 2017

Sources of Hematopoietic Stem and Progenitor Cells and Methods to Optimize Yields for Clinical Cell Therapy.

Biol Blood Marrow Transplant 2017 Aug 8;23(8):1241-1249. Epub 2017 May 8.

Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.05.003DOI Listing
August 2017

Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Cancer 2017 Jul 22;123(14):2671-2679. Epub 2017 Mar 22.

Acute Leukemia Working Party, European Society for Blood and Marrow Transplantation Paris Study Office/European Center for Biostatistical and Epidemiological Evaluation in Hematopoietic Cell Therapy (CEREST-TC), Paris, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.30646
Publisher Site
http://dx.doi.org/10.1002/cncr.30646DOI Listing
July 2017

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

Biol Blood Marrow Transplant 2017 Jun 14;23(6):870-881. Epub 2016 Oct 14.

University of Florida Health Cancer Center, Gainesville, Florida; Bone Marrow Transplant Program, Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.10.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392182PMC
June 2017

Making inroads to the cure: Barriers to clinical trial enrollment in hematopoietic cell transplantation.

Clin Transplant 2017 05 17;31(5). Epub 2017 Apr 17.

Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ctr.12948DOI Listing
May 2017

Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group Diagnostic Criteria as a Chronic Ocular GVHD-Specific Metric.

Cornea 2017 Feb;36(2):258-263

*Vanderbilt Eye Institute, Vanderbilt University School of Medicine, Nashville, TN; †Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, Boston, MA; ‡Department of Medicine, Division of Hematology/Oncology, Vanderbilt University School of Medicine, Nashville, TN; and §Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/ICO.0000000000001109DOI Listing
February 2017

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes.

Biol Blood Marrow Transplant 2017 01 29;23(1):6-9. Epub 2016 Oct 29.

Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Rockville, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.10.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182086PMC
January 2017

Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies.

Biol Blood Marrow Transplant 2016 10 1;22(10):1801-1807. Epub 2016 Jul 1.

Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Division of Hematology/Oncology, Stem Cell Transplantation, Department of Medicine, Vanderbilt University, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.06.029DOI Listing
October 2016

Programmed death-1 immune checkpoint blockade in the treatment of hematological malignancies.

Ann Med 2016 09 25;48(6):428-439. Epub 2016 May 25.

c Hematology Division , Chaim Sheba Medical Center , Tel Hashomer , Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07853890.2016.1186827DOI Listing
September 2016

Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.

J Clin Oncol 2016 09 6;34(26):3141-9. Epub 2016 Jun 6.

Nilanjan Ghosh, Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC; Reem Karmali, Rush University Medical Center; Sonali M. Smith, The University of Chicago, Chicago, IL; Vanderson Rocha, Churchill Hospital, Oxford, United Kingdom; Kwang Woo Ahn, Alyssa DiGilio, and Mehdi Hamadani, Medical College of Wisconsin & Center for International Blood and Marrow Transplant Research; Parameswaran N. Hari and Anita D'Souza, Medical College of Wisconsin; Timothy S. Fenske, Froedtert Memorial Lutheran Hospital, Milwaukee, WI; Veronika Bachanova, University of Minnesota Medical Center, Minneapolis, MN; Ulrike Bacher, University Medicine Goettingen and University Cancer Center Hamburg, Hamburg, Germany; Parastoo Dahi, Memorial Sloan Kettering Cancer Center-Adults, New York, NY; Marcos de Lima, University Hospitals Case Medical Center, Cleveland; Samantha Jaglowski, The Ohio State University Medical Center, Columbus, OH; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Mohamed A. Kharfan-Dabaja, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Tim D. Prestidge, Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand; Bipin N. Savani, Vanderbilt University Medical Center, Nashville, TN; Anna M. Sureda, European Group for Blood and Marrow Transplantation and Hospital Duran I Reynals, Barcelona, Spain; Edmund K. Waller, Winship Cancer Institute, Emory University, Atlanta, GA; Alex F. Herrera, City of Hope National Medical Center, Duarte, CA; Philippe Armand, Dana-Farber Cancer Institute, Boston, MA; Rachel B. Salit, Fred Hutchinson Cancer Research Center, Seattle, WA; and Nina D. Wagner-Johnston, Ephraim Fuchs, and Javier Bolaños-Meade, Johns Hopkins University Sidney Kimmel Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.3476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012706PMC
September 2016

Immune-Mediated Complications after Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2016 08 14;22(8):1368-1375. Epub 2016 Apr 14.

Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center and Veterans Affairs Medical Center, Nashville, Tennessee. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.04.005DOI Listing
August 2016

Therapy-related myeloid neoplasms - what have we learned so far?

World J Stem Cells 2016 Aug;8(8):231-42

Mohammad Faizan Zahid, Medical College, Aga Khan University, Karachi 74800, Pakistan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4252/wjsc.v8.i8.231DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999650PMC
August 2016

Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Exp Hematol 2016 07 19;44(7):567-73. Epub 2016 Apr 19.

Chaim Sheba Medical Center, Tel-Hashomer, Israel; Acute Leukemia Working Party Office, Hôpital Saint Antoine, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2016.04.005DOI Listing
July 2016

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

J Clin Oncol 2016 06 4;34(16):1864-71. Epub 2016 Apr 4.

Brian C. Shaffer and Martin Tallman, Memorial Sloan Kettering Cancer Center; Adriana K. Malone, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai; Ran Reshef, Columbia University Medical Center, New York; Mark Litzow, Mayo Clinic Rochester; Jane Liesveld, University of Rochester Medical Center, Rochester; Peter H. Wiernik, Our Lady of Mercy Medical Center, Bronx, NY; Kwang Woo Ahn, Zhen-Huan Hu, and Wael Saber, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI; Taiga Nishihori and Mohamed A. Kharfan-Dabaja, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; David Valcárcel, Hospital Vall d'Hebron, Barcelona, Spain; Michael R. Grunwald, Omotayo Fasan, and Edward Copelan, Levine Cancer Institute, Carolinas HealthCare System, Charlotte; William Allen Wood, University of North Carolina at Chapel Hill, Chapel Hill; David A. Rizzieri, Duke University Medical Center, Durham, NC; Ulrike Bacher, University of Medicine Göttingen, Göttingen, Germany; Betty Hamilton and Aaron Gerds, Cleveland Clinic Taussig Cancer Institute; Matt Kalaycio and Ron Sobecks, Cleveland Clinic Foundation, Cleveland; Basem William, Ohio State University Medical Center, Columbus, OH; Ayman Saad and Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Corey Cutler and Edwin Alyea, Dana-Farber Cancer Institute, Boston, MA; Erica Warlick and Celalettin Ustun, University of Minnesota Medical Center, Minneapolis, MN; Baldeep Mona Wirk, Seattle Cancer Care Alliance, Seattle, WA; Mitchell Sabloff, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, Ontario; Andrew Daly, Tom Baker Cancer Center, Calgary, Alberta, Canada; David Marks, University Hospitals Bristol National Health Service Trust, Bristol; Robert Peter Gale, Imperial College London, London, United Kingdom; Richard Olsson, Karolinska Institutet, Stockholm, Sweden; Alan M. Miller, Baylor University Medical Center; Rammurti Kamble

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.0515DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966345PMC
June 2016

Haploidentical transplantation: selecting optimal conditioning regimen and stem cell source.

Semin Hematol 2016 Apr 15;53(2):111-4. Epub 2016 Jan 15.

EBMT Paris study office/CEREST-TC, Paris, France; University Pierre & Marie Curie, Paris, France; Hopital Saint-Antoine, AP-HP; INSERM UMRs U938, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2016.01.012DOI Listing
April 2016